Related Experiment Videos
[Lack of correlation between HLA haplotypes and familial hypertrophic cardiomyopathy]
Insights
This study investigated human leukocyte antigen (HLA) antigens in a family with hypertrophic cardiomyopathy (HCM). The findings did not establish a consistent genetic link between specific HLA aplotypes and HCM in this family.
Area of Science:
- Immunogenetics
- Cardiology
- Human Genetics
Context:
- Familial hypertrophic cardiomyopathy (HCM) is a significant genetic heart condition.
- Previous research suggested associations between specific human leukocyte antigen (HLA) antigens and HCM.
- Understanding the genetic underpinnings of HCM is crucial for diagnosis and management.
Purpose:
- To investigate the association between HLA-A, B, and C antigens and familial hypertrophic cardiomyopathy.
- To analyze HLA antigen profiles within a family exhibiting a high prevalence of HCM.
- To determine if specific HLA aplotypes correlate with the presence or type of HCM.
Summary:
- Human leukocyte antigen (HLA) typing was performed on family members, including six affected by hypertrophic cardiomyopathy.
- A specific HLA aplotype (A9, Bw35, Cw4) was observed in some affected individuals but not consistently.
- The study found no definitive correlation between HLA aplotypes and hypertrophic cardiomyopathy in this family.
- The presence of the A9, Bw35, Cw4 aplotype in a healthy family member and its absence in one affected member further complicated the association.
Impact:
- This research highlights the complexity of genetic factors in hypertrophic cardiomyopathy.
- The findings suggest that HLA antigen associations with HCM may not be straightforward or universally applicable.
- Further genetic studies are needed to elucidate the etiology of familial hypertrophic cardiomyopathy.
Abstract:
In order to confirm the recent observations of the particular incidence of some HLA antigens in the familial hypertrophic cardiomyopathy we have determined the HLA-A, B and C antigens in the components of a family with high prevalence of hypertrophic cardiomyopathy (10 males and 7 females, age from 10 to 75 years). Six patients were affected by the disease. In one case (sudden death) the diagnosis was established by necroscopy; in the other living subjects by the characteristic echocardiographic features after having ruled out the conditions which can result in secondary myocardial hypertrophy. HLA typing showed the A9, Bw35, Cw4 aplotype in 4 of the 5 living patients affected by hypertrophic cardiomyopathy (2 with obstruction). This aplotype however was not shared by the other patient and was found in one healthy member of the family. Two patients affected by hypertrophic cardiomyopathy without obstruction did not share any aplotype while the 2 subjects with obstructive hypertrophic cardiomyopathy had the same aplotype of a healthy member of the family. Accordingly the genetic study of this family does not allow to establish a steady correlation between hypertrophic cardiomyopathy and HLA aplotypes.